Evaluating a shared care pathway intervention for people receiving chemotherapy to reduce post-treatment unplanned hospital presentations: a randomised controlled trial

Author:

Fethney JudithORCID,Kim Bora,Boustany Chantale,McKenzie Heather,Hayes Lillian,Cox Keith,Simpson Judy M.,Horvath Lisa G.,Vardy Janette L.,McLeod Jodi,Willcock Simon,Cook Natalie,Acret Louise,White Kate

Abstract

Abstract Purpose The aim of this randomised controlled trial (RCT) was to explore whether a community nursing intervention for outpatients receiving systemic therapy reduced unplanned hospital presentations and improved physical and psychosocial health outcomes over the first three cycles of treatment compared to a control group receiving standard care. Methods The number of and reasons for unplanned presentations were obtained for 170 intervention and 176 control group adult patients with solid tumours starting outpatient chemotherapy. Poisson regression was used to compare the number of presentations between the intervention and control groups. Patients self-completed the Hospital Anxiety and Depression Scale, the Cancer Behavior Inventory and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire core 30 (EORTC QLQ-C30) at the start of the first four cycles. Linear regression techniques were used to compare quality of life outcomes. Results The reduction in unplanned presentations in the intervention group relative to the control group was 12% (95% CI, − 25%, 37%; P = 0.48). At the start of cycle 4, there was no difference in anxiety (difference = 0.47 (95% CI, − 0.28, 1.22; P = 0.22)), depression (difference = 0.57 (95% CI, − 0.18, 1.31; P = 0.13)) or EORTC QLQ-C30 summary score (difference = 0.16 (95% CI, − 2.67, 3.00; P = 0.91)). Scores for self-efficacy as measured by the Cancer Behavior Inventory were higher in the intervention group (difference = 4.3 (95% CI, 0.7, 7.9; P = 0.02)). Conclusion This RCT did not demonstrate a benefit in reducing unplanned presentations to hospital. The trial identified improved cancer-based self-efficacy in patients receiving the intervention. Trial registration Registered at Australian and New Zealand Clinical Trials Registry: ACTRN12614001113640, registered 21/10/2014.

Funder

National Health and Medical Research Council

University of Sydney

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Reference47 articles.

1. Kristensen SR, Bech M, Quentin W (2015) A roadmap for comparing readmission policies with application to Denmark, England, Germany and the United States. Health Policy 119(3):264–273

2. Department of Health. Keeping Australians Out of Hospital. 2019; Available from: https://www.health.gov.au/initiatives-and-programs/keeping-australians-out-of-hospital. Accessed 28 September 2020

3. Council of Australian Governments (2018) Heads of Agreement between the Commonwealth and the States and Territories on public hospital funding and health reform. 2018: Australia. https://federation.gov.au/about/agreements/heads-agreement-between-commonwealth-and-states-and-territories-public-hospital. Accessed 28 September 2020

4. McKenzie H et al (2011) Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective study. Support Care Cancer 19(7):963–969. https://doi.org/10.1007/s00520-010-0913-y

5. National Cancer Control Indicators. Systemic anti-cancer therapy treatment activity. (2017) https://ncci.canceraustralia.gov.au/treatment/systemic-anti-cancer-therapy-treatment-activity/systemic-anti-cancer-therapy-treatment. Accessed 6th April 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3